BSN JD - Nutex Health Chief Sec
| NUTX Stock | USD 34.22 1.31 3.98% |
Insider
BSN JD is Chief Sec of Nutex Health
| Address | 6030 South Rice Avenue, Houston, TX, United States, 77081 |
| Phone | 713 660 0557 |
| Web | https://www.nutexhealth.com |
Nutex Health Management Efficiency
The company has return on total asset (ROA) of 0.0376 % which means that it generated a profit of $0.0376 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.351) %, meaning that it created substantial loss on money invested by shareholders. Nutex Health's management efficiency ratios could be used to measure how well Nutex Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.13 in 2024. Return On Capital Employed is likely to rise to -0.09 in 2024. At this time, Nutex Health's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 322.8 M in 2024, whereas Total Current Assets are likely to drop slightly above 53.7 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Wei Chen | EUDA Health Holdings | 39 | |
| Wendy Lucio | Streamline Health Solutions | N/A | |
| Sudish Mogli | Healthcare Triangle | 55 | |
| Lakshmanan Kannappan | Healthcare Triangle | 57 | |
| Donald Vick | Streamline Health Solutions | 60 | |
| Kristi Lane | Healthcare Triangle | N/A | |
| Susan Neo | FOXO Technologies | N/A | |
| Shibu Kizhakevilayil | Healthcare Triangle | 52 | |
| Steven Sabes | FOXO Technologies | 56 | |
| Daniel Tan | EUDA Health Holdings | 43 | |
| Jacob Goldberger | Streamline Health Solutions | N/A | |
| Jon Boumstein | National Research Corp | N/A | |
| Peter Grua | Evolent Health | 66 | |
| Robert Potashnick | FOXO Technologies | N/A | |
| Steven Sobak | EUDA Health Holdings | 78 | |
| Aammaad Shams | Evolent Health | 40 | |
| M Duffy | Evolent Health | 61 | |
| Craig Barbarosh | Evolent Health | 52 | |
| Thyagarajan Ramachandran | Healthcare Triangle | 48 | |
| Jona Raasch | National Research Corp | 65 | |
| FACC MD | Heartbeam | 65 | |
Management Performance
| Return On Equity | -0.35 | ||||
| Return On Asset | 0.0376 |
Nutex Health Leadership Team
Elected by the shareholders, the Nutex Health's board of directors comprises two types of representatives: Nutex Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nutex. The board's role is to monitor Nutex Health's management team and ensure that shareholders' interests are well served. Nutex Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nutex Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Warren MD, President Director | ||
| Vivian MBA, Director Marketing | ||
| BSN JD, Chief Sec | ||
| Elizabeth Hall, HR Mang | ||
| Jon Bates, Chief Officer | ||
| MD MBA, Chairman CEO | ||
| Lawrence FACS, Chief Officer | ||
| Esq JD, Chief Secretary | ||
| Sarah Wallace, Director Resources | ||
| LaTanya Brackens, Director Compliance | ||
| LaChoenda Rosales, Director Accounting | ||
| Denise Pufal, Director Operations | ||
| Michael MD, Chief Officer | ||
| MBA FACHE, Chief Officer |
Nutex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nutex Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.35 | ||||
| Return On Asset | 0.0376 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 442.38 M | ||||
| Shares Outstanding | 5.44 M | ||||
| Shares Owned By Insiders | 39.05 % | ||||
| Shares Owned By Institutions | 8.80 % | ||||
| Number Of Shares Shorted | 35.67 K | ||||
| Price To Earning | 3.90 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nutex Stock Analysis
When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.